Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers
Ruiying Zhao(The University of Texas MD Anderson Cancer Center), Mong-Hong Lee, You‐Tzung Chen(National Taiwan University), Fanmao Zhang(The University of Texas MD Anderson Cancer Center), Ayşegül A. Şahin(The University of Texas MD Anderson Cancer Center), Tomoo Iwakuma(Louisiana State University Health Sciences Center New Orleans), Changju Qu(The University of Texas MD Anderson Cancer Center), Tattym E. Shaiken(The University of Texas MD Anderson Cancer Center), Guillermina Lozano(The University of Texas MD Anderson Cancer Center), Sai‐Ching J. Yeung(The University of Texas MD Anderson Cancer Center), Dung‐Fang Lee(Brown Foundation), Feng Jin(China Medical University), Jian Chen(Jiangsu University), Hua Wang(Scripps Research Institute), Bo Chen(Howard Hughes Medical Institute), Rui Zhu(The University of Texas MD Anderson Cancer Center), Huamin Wang(The University of Texas MD Anderson Cancer Center), Yu Lin(The University of Texas MD Anderson Cancer Center), Chun-Hui Su(The University of Texas MD Anderson Cancer Center), Chien‐Chen Lai(National Chung Hsing University), Fuu Jen Tsai(China Medical University), Dos D. Sarbassov(Nazarbayev University)
Cited by 106
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Mdm2-mediated ubiquitylation: p53 and beyond
|Cell Death and Differentiation|2009|351
Viscoelastic surface electrode arrays to interface with viscoelastic tissues
|Nature Nanotechnology|2021|302